{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:25:50Z","timestamp":1790889950907,"version":"4.1.0"},"reference-count":73,"publisher":"MDPI AG","issue":"22","license":[{"start":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T00:00:00Z","timestamp":1637366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP21ek0210152, JP21gm6210010, JP20bm0704026, JP21ek0210141, JP21ek0109440, JP21ek0109487, JP21gm0810013, JP21km0405209, JP21ek0210118, JP21ek0109406, JP21ek0109543, JP21ek0109569"],"award-info":[{"award-number":["JP21ek0210152, JP21gm6210010, JP20bm0704026, JP21ek0210141, JP21ek0109440, JP21ek0109487, JP21gm0810013, JP21km0405209, JP21ek0210118, JP21ek0109406, JP21ek0109543, JP21ek0109569"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>With the development and advancement of next-generation sequencing (NGS), genetic analysis is becoming more accessible. High-throughput genetic studies using NGS have contributed to unraveling the association between cardiomyopathy and genetic background, as is the case with many other diseases. Rare variants have been shown to play major roles in the pathogenesis of cardiomyopathy, which was empirically recognized as a monogenic disease, and it has been elucidated that the clinical course of cardiomyopathy varies depending on the causative genes. These findings were not limited to dilated and hypertrophic cardiomyopathy; similar trends were reported one after another for peripartum cardiomyopathy (PPCM), cancer therapy-related cardiac dysfunction (CTRCD), and alcoholic cardiomyopathy (ACM). In addition, as the association between clinical phenotypes and the causative genes becomes clearer, progress is being made in elucidating the mechanisms and developing novel therapeutic agents. Recently, it has been suggested that not only rare variants but also common variants contribute to the development of cardiomyopathy. Cardiomyopathy and genetics are approaching a new era, which is summarized here in this overview.<\/jats:p>","DOI":"10.3390\/ijms222212522","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T20:58:21Z","timestamp":1637528301000},"page":"12522","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Recent Findings Related to Cardiomyopathy and Genetics"],"prefix":"10.3390","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8258-4219","authenticated-orcid":false,"given":"Takanobu","family":"Yamada","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2957-2016","authenticated-orcid":false,"given":"Seitaro","family":"Nomura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-8654, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/eurheartj\/ehm342","article-title":"Classification of the Cardiomyopathies: A Position Statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"29","author":"Elliott","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jacc.2015.01.019","article-title":"New Perspectives on the Prevalence of Hypertrophic Cardiomyopathy","volume":"65","author":"Semsarian","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.amjcard.2016.02.044","article-title":"Occurrence of Clinically Diagnosed Hypertrophic Cardiomyopathy in the United States","volume":"117","author":"Maron","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S0140-6736(16)31713-5","article-title":"Dilated Cardiomyopathy","volume":"390","author":"Weintraub","year":"2017","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated Cardiomyopathy: The Complexity of a Diverse Genetic Architecture","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-I","article-title":"A Molecular Basis for Familial Hypertrophic Cardiomyopathy: A p Cardiac Myosin Heavy Chain Gene Missense Mutation","volume":"62","author":"Kass","year":"1990","journal-title":"Cell"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1126\/science.280.5364.750","article-title":"Actin Mutations in Dilated Cardiomyopathy, a Heritable Form of Heart Failure","volume":"280","author":"Olson","year":"1998","journal-title":"Science"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/CIRCRESAHA.116.309396","article-title":"Dilated Cardiomyopathy: Genetic Determinants and Mechanisms","volume":"121","author":"McNally","year":"2017","journal-title":"Circ. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/gim.2013.204","article-title":"The Landscape of Genetic Variation in Dilated Cardiomyopathy as Surveyed by Clinical DNA Sequencing","volume":"16","author":"Pugh","year":"2014","journal-title":"Genet. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1038\/s41598-018-20114-9","article-title":"Genetic Basis of Cardiomyopathy and the Genotypes Involved in Prognosis and Left Ventricular Reverse Remodeling","volume":"8","author":"Tobita","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCULATIONAHA.119.039573","article-title":"Genomics-First Evaluation of Heart Disease Associated with Titin-Truncating Variants","volume":"140","author":"Haggerty","year":"2019","journal-title":"Circulation"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1001\/jama.2018.18179","article-title":"Association between Titin Loss-of-Function Variants and Early-Onset Atrial Fibrillation","volume":"320","author":"Choi","year":"2018","journal-title":"JAMA"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJM199912023412302","article-title":"Missense Mutations in the Rod Domain of the Lamin A\/C Gene as Causes of Dilated Cardiomyopathy and Conduction-System Disease","volume":"341","author":"Fatkin","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/eurheartj\/ehx650","article-title":"Lamin A\/C Mutations in Patients with Dilated Cardiomyopathy","volume":"39","author":"Hasselberg","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1093\/eurheartj\/ehv316","article-title":"2015 ESC Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC)","volume":"36","author":"Priori","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1016\/j.jacc.2021.08.039","article-title":"Association of Genetic Variants With Outcomes in Patients With Nonischemic Dilated Cardiomyopathy","volume":"78","author":"Ochoa","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11886-020-01437-4","article-title":"Hypertrophic Cardiomyopathy: Genetic Testing and Risk Stratification","volume":"23","author":"Stafford","year":"2021","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/CIRCRESAHA.121.318346","article-title":"Molecular Genetic Basis of Hypertrophic Cardiomyopathy","volume":"128","author":"Marian","year":"2021","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13073-019-0616-z","article-title":"Quantitative Approaches to Variant Classification Increase the Yield and Precision of Genetic Testing in Mendelian Diseases: The Case of Hypertrophic Cardiomyopathy","volume":"11","author":"Walsh","year":"2019","journal-title":"Genome Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1136\/heartjnl-2013-303939","article-title":"A Systematic Review and Meta-Analysis of Genotype-Phenotype Associations in Patients with Hypertrophic Cardiomyopathy Caused by Sarcomeric Protein Mutations","volume":"99","author":"Lopes","year":"2013","journal-title":"Heart"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/CIRCULATIONAHA.117.033200","article-title":"Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)","volume":"138","author":"Ho","year":"2018","journal-title":"Circulation"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCULATIONAHA.120.047235","article-title":"A Validated Model for Sudden Cardiac Death Risk Prediction in Pediatric Hypertrophic Cardiomyopathy","volume":"142","author":"Miron","year":"2020","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","article-title":"Clinical Phenotype and Outcome of Hypertrophic Cardiomyopathy Associated with Thin-Filament Gene Mutations","volume":"64","author":"Coppini","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Marstrand, P., Han, L., Day, S.M., Olivotto, I., Ashley, E.A., Michels, M., Pereira, A.C., Wittekind, S.G., Helms, A., and Saberi, S. (2020). Hypertrophic Cardiomyopathy with Left Ventricular Systolic Dysfunction: Insights from the SHaRe Registry. Circulation, 1371\u20131383.","DOI":"10.1161\/CIRCULATIONAHA.119.044366"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s00392-017-1155-5","article-title":"Clinical Outcomes Associated with Sarcomere Mutations in Hypertrophic Cardiomyopathy: A Meta-Analysis on 7675 Individuals","volume":"107","author":"Kayvanpour","year":"2018","journal-title":"Clin. Res. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/CIRCULATIONAHA.118.034624","article-title":"A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay","volume":"139","author":"Seeger","year":"2019","journal-title":"Circulation"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"eaat1199","DOI":"10.1126\/scitranslmed.aat1199","article-title":"Hypertrophic Cardiomyopathy Mutations in MYBPC3 Dysregulate Myosin","volume":"11","author":"Toepfer","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A Small-Molecule Inhibitor of Sarcomere Contractility Suppresses Hypertrophic in Mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.119.042339","article-title":"Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic Cardiomyopathy","volume":"141","author":"Toepfer","year":"2020","journal-title":"Circulation"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"Mavacamten for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (EXPLORER-HCM): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJMoa1110186","article-title":"Truncations of Titin Causing Dilated Cardiomyopathy","volume":"366","author":"Herman","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"ref_32","first-page":"982","article-title":"Titin Mutations in IPS Cells Define Sarcomere Insufficiency as a Cause of Dilated Cardiomyopathy","volume":"349","author":"Hinson","year":"2015","journal-title":"Heart Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.devcel.2017.12.012","article-title":"Force Generation via \u03b2-Cardiac Myosin, Titin, and \u03b1-Actinin Drives Cardiac Sarcomere Assembly from Cell-Matrix Adhesions","volume":"44","author":"Chopra","year":"2018","journal-title":"Dev. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/ng.3719","article-title":"Titin-Truncating Variants Affect Heart Function in Disease Cohorts and the General Population","volume":"49","author":"Schafer","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/nm.2693","article-title":"RBM20, a Gene for Hereditary Cardiomyopathy, Regulates Titin Splicing","volume":"18","author":"Guo","year":"2012","journal-title":"Nat. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/CIRCULATIONAHA.119.039521","article-title":"Cronos Titin Is Expressed in Human Cardiomyocytes and Necessary for Normal Sarcomere Function","volume":"140","author":"Zaunbrecher","year":"2019","journal-title":"Circulation"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-019-1406-x","article-title":"Activation of PDGF Pathway Links LMNA Mutation to Dilated Cardiomyopathy","volume":"572","author":"Lee","year":"2019","journal-title":"Nature"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1161\/CIRCRESAHA.118.314238","article-title":"DNA Damage Response\/TP53 Pathway Is Activated and Contributes to the Pathogenesis of Dilated Cardiomyopathy Associated with LMNA (Lamin A\/C) Mutations","volume":"124","author":"Chen","year":"2019","journal-title":"Circ. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4740","DOI":"10.1172\/JCI135922","article-title":"BET Bromodomain Inhibition Attenuates Cardiac Phenotype in Myocyte-Specific Lamin A\/C-Deficient Mice","volume":"130","author":"Auguste","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e136488","DOI":"10.1172\/JCI136488","article-title":"Targeting the Histone Demethylase LSD1 Prevents Cardiomyopathy in a Mouse Model of Laminopathy","volume":"131","author":"Jebeniani","year":"2021","journal-title":"J. Clin. Investig."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41467-019-09929-w","article-title":"The K219T-Lamin Mutation Induces Conduction Defects through Epigenetic Inhibition of SCN5A in Human Cardiac Laminopathy","volume":"10","author":"Salvarani","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1083\/jcb.201902117","article-title":"Chromatin Compartment Dynamics in a Haploinsufficient Model of Cardiac Laminopathy","volume":"218","author":"Bertero","year":"2019","journal-title":"J. Cell Biol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1161\/CIRCRESAHA.118.314177","article-title":"Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes Is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy","volume":"124","author":"Cheedipudi","year":"2019","journal-title":"Circ. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.devcel.2019.04.020","article-title":"Mechanosensing by the Lamina Protects against Nuclear Rupture, DNA Damage, and Cell-Cycle Arrest","volume":"49","author":"Cho","year":"2019","journal-title":"Dev. Cell"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e012937","DOI":"10.1161\/JAHA.119.012937","article-title":"Exercise Is Associated with Impaired Left Ventricular Systolic Function in Patients With Lamin A\/C Genotype","volume":"9","author":"Hasselberg","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1161\/CIRCULATIONAHA.119.045118","article-title":"Distinct Cardiac Transcriptomic Clustering in Titin and Lamin A\/C-Associated Dilated Cardiomyopathy Patients","volume":"142","author":"Verdonschot","year":"2020","journal-title":"Circulation"},{"key":"ref_47","first-page":"326","article-title":"Dilated Cardiomyopathy and Arrhythmogenic Left Ventricular Cardiomyopathy: A Comprehensive Genotype-Imaging Phenotype Study","volume":"21","author":"Augusto","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/j.jacc.2019.06.072","article-title":"Genetic Risk of Arrhythmic Phenotypes in Patients with Dilated Cardiomyopathy","volume":"74","author":"Gigli","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMoa2025797","article-title":"Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure","volume":"384","author":"Teerlink","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jacc.2011.03.047","article-title":"Clinical Characteristics of Peripartum Cardiomyopathy in the United States: Diagnosis, Prognosis, and Management","volume":"58","author":"Elkayam","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","article-title":"Peripartum Cardiomyopathy","volume":"368","author":"Sliwa","year":"2006","journal-title":"Lancet"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrcardio.2014.37","article-title":"Pathophysiology and Epidemiology of Peripartum Cardiomyopathy","volume":"11","author":"Sliwa","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1505517","article-title":"Shared Genetic Predisposition in Peripartum and Dilated Cardiomyopathies","volume":"374","author":"Ware","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1161\/CIRCULATIONAHA.120.052395","article-title":"Genetic and Phenotypic Landscape of Peripartum Cardiomyopathy","volume":"143","author":"Goli","year":"2021","journal-title":"Circulation"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ehjci\/jeu192","article-title":"Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1093\/eurheartj\/ehw211","article-title":"2016 ESC Position Paper on Cancer Treatments and Cardiovascular Toxicity Developed under the Auspices of the ESC Committee for Practice Guidelines","volume":"37","author":"Zamorano","year":"2016","journal-title":"Eur. Heart J."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","article-title":"Cardiovascular Toxicity Induced by Chemotherapy, Targeted Agents and Radiotherapy: ESMO Clinical Practice Guidelines","volume":"23","author":"Curigliano","year":"2012","journal-title":"Ann. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","article-title":"Cardiovascular Disease among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study","volume":"34","author":"Armenian","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of Anthracycline-Induced Cardiotoxicity Challenges and Opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1161\/CIRCULATIONAHA.118.037934","article-title":"Genetic Variants Associated with Cancer Therapy-Induced Cardiomyopathy","volume":"140","author":"Kim","year":"2019","journal-title":"Circulation"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJM198902163200701","article-title":"The Effects of Alcoholism on Skeletal and Cardiac Muscle","volume":"320","author":"Estruch","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_62","first-page":"78","article-title":"Natural History and Prognostic Factors in Alcoholic Cardiomyopathy","volume":"3","author":"Segovia","year":"2015","journal-title":"J. Am. Coll. Cardiol. Heart Fail."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2018.03.462","article-title":"Genetic Etiology for Alcohol-Induced Cardiac Toxicity","volume":"71","author":"Ware","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1093\/eurheartj\/ehr105","article-title":"A Genome-Wide Association Study Identifies Two Loci Associated with Heart Failure Due to Dilated Cardiomyopathy","volume":"32","author":"Villard","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1093\/eurheartj\/eht251","article-title":"A Genome-Wide Association Study Identifies 6p21 as Novel Risk Locus for Dilated Cardiomyopathy","volume":"35","author":"Meder","year":"2014","journal-title":"Eur. Heart J."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1038\/s41467-020-15823-7","article-title":"Analysis of Cardiac Magnetic Resonance Imaging in 36,000 Individuals Yields Genetic Insights into Dilated Cardiomyopathy","volume":"11","author":"Pirruccello","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41588-020-00764-0","article-title":"Common Genetic Variants and Modifiable Risk Factors Underpin Hypertrophic Cardiomyopathy Susceptibility and Expressivity","volume":"53","author":"Harper","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41588-020-00762-2","article-title":"Shared Genetic Pathways Contribute to Risk of Hypertrophic and Dilated Cardiomyopathies with Opposite Directions of Effect","volume":"53","author":"Tadros","year":"2021","journal-title":"Nat. Genet."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-Wide Association and Mendelian Randomisation Analysis Provide Insights into the Pathogenesis of Heart Failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e000067","DOI":"10.1161\/HCG.0000000000000067","article-title":"Genetic Testing for Inherited Cardiovascular Diseases: A Scientific Statement from the American Heart Association","volume":"13","author":"Musunuru","year":"2020","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jacc.2020.06.011","article-title":"Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers","volume":"76","author":"Lorenzini","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.jacc.2021.07.017","article-title":"Phenotypic Expression and Outcomes in Individuals with Rare Genetic Variants of Hypertrophic Cardiomyopathy","volume":"78","author":"McGurk","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1038\/s41436-019-0582-2","article-title":"A Cost-Effectiveness Model of Genetic Testing and Periodical Clinical Screening for the Evaluation of Families with Dilated Cardiomyopathy","volume":"21","author":"Catchpool","year":"2019","journal-title":"Genet. Med."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12522\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:33:17Z","timestamp":1760167997000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/22\/12522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,20]]},"references-count":73,"journal-issue":{"issue":"22","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222212522"],"URL":"https:\/\/doi.org\/10.3390\/ijms222212522","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,20]]}}}